EBOS Group

EBOS Group Debt/EBITDA

The Total Debt to EBITDA Ratio of EBOS Group (EBO.NZ) as of Oct 29, 2026 is 6.51. In the previous year, Total Debt to EBITDA Ratio was 2.68 — a change of 143.21% (higher).

Debt/EBITDA

6.51

YoY

143.21%

Last updated:

Total Debt to EBITDA Ratio of EBOS Group is 2026 6.51 . Total Debt to EBITDA Ratio of EBOS Group was 2025 2.68 . It decreases by 143.21% higher compared to the previous year.

The EBOS Group Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2019
1.99 AUD
Jan 1, 2020
2.28 AUD
Jan 1, 2021
1.77 AUD
Jan 1, 2022
3.60 AUD
Jan 1, 2023
2.13 AUD
Jan 1, 2024
2.56 AUD
Jan 1, 2025
2.68 AUD
Jan 1, 2026
6.51 AUD
The EBOS Group Debt/EBITDA history
YEARDebt/EBITDAYoY
6.51+143.21%
2.68+4.69%
2.56+19.93%
2.13-40.78%
3.60+103.89%
1.77-22.69%
2.28+14.91%
1.99-12.15%
2.26+80.15%
1.26+49.54%
0.84-23.21%
1.09-50.76%
2.22—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

EBOS Group Stock analysis

What does EBOS Group do? The EBOS Group was founded in New Zealand in 2000 and has since grown to become one of the largest healthcare companies in the region. The company's business model is to provide solutions for the healthcare industry, ranging from products for pharmacies, hospitals, and medical practices to healthcare services. The company is divided into several divisions, including healthcare distribution, dental, and healthcare services. The healthcare distribution division focuses on distributing pharmaceutical products, medical devices, and other healthcare items to healthcare facilities. This includes surgical instruments and oncology products. The dental division specializes in selling and distributing dental products, such as instruments for dentists and consumables like gloves, implants, and floss. They also offer services for dentists, including a dental practice built in partnership with another company. The healthcare services division includes the distribution of home care and healthcare products, as well as the rental of medical equipment like wheelchairs and beds. EBOS Group also provides services such as consultation and training for patients, caregivers, and healthcare providers. With a strong emphasis on quality and customer satisfaction, EBOS Group has a successful track record and has acquired and developed several companies in the region. Their products help improve patient health and contribute to reducing healthcare costs. The company plays a vital role in the healthcare products and services market. The EBOS Group's diverse divisions and wide range of products secure its position as an important player in the healthcare industry. EBOS Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EBOS Group stock

Total Debt to EBITDA Ratio of EBOS Group is 6.51 in 2026.

Total Debt to EBITDA Ratio of EBOS Group changed from 2.68 to 6.51, representing a 143.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio EBOS Group since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's EBOS Group with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — EBOS Group

All Key Metrics — EBOS Group